Pharma & Healthcare
Global Infliximab Injection Market Research Report 2026
- May 01, 26
- ID: 748644
- Pages: 112
- Figures: 112
- Views: 9
This report delivers a comprehensive overview of the global Infliximab Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Infliximab Injection. The Infliximab Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Infliximab Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Infliximab Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Celltrion
Janssen Biologics
Hangzhou Bozhirui Biopharmaceuticals
Taizhou Maiboteike Pharmaceuticals
Yuxi Jiahe Biotechnology
Ayumi Pharmaceuticals
Pfizer
Nichiiko
Nippon Kayaku
AMGEN
Segment by Type
Original Drug
Generic Drug
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Infliximab Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Infliximab Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Infliximab Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Infliximab Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Celltrion
Janssen Biologics
Hangzhou Bozhirui Biopharmaceuticals
Taizhou Maiboteike Pharmaceuticals
Yuxi Jiahe Biotechnology
Ayumi Pharmaceuticals
Pfizer
Nichiiko
Nippon Kayaku
AMGEN
Segment by Type
Original Drug
Generic Drug
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Infliximab Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Infliximab Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Infliximab Injection Market Overview
1.1 Product Definition
1.2 Infliximab Injection by Type
1.2.1 Global Infliximab Injection Market Value by Type: 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Infliximab Injection by Application
1.3.1 Global Infliximab Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Infliximab Injection Market Size Estimates and Forecasts
1.4.1 Global Infliximab Injection Revenue 2021–2032
1.4.2 Global Infliximab Injection Sales 2021–2032
1.4.3 Global Infliximab Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Infliximab Injection Market Competition by Manufacturers
2.1 Global Infliximab Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Infliximab Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Infliximab Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Infliximab Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Infliximab Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Infliximab Injection, Product Types and Applications
2.7 Global Key Manufacturers of Infliximab Injection, Date of Entry into the Industry
2.8 Global Infliximab Injection Market Competitive Situation and Trends
2.8.1 Global Infliximab Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Infliximab Injection Players Market Share by Revenue
2.8.3 Global Infliximab Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Infliximab Injection Market Scenario by Region
3.1 Global Infliximab Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Infliximab Injection Sales by Region: 2021–2032
3.2.1 Global Infliximab Injection Sales by Region: 2021–2026
3.2.2 Global Infliximab Injection Sales by Region: 2027–2032
3.3 Global Infliximab Injection Revenue by Region: 2021–2032
3.3.1 Global Infliximab Injection Revenue by Region: 2021–2026
3.3.2 Global Infliximab Injection Revenue by Region: 2027–2032
3.4 North America Infliximab Injection Market Facts & Figures by Country
3.4.1 North America Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Infliximab Injection Sales by Country (2021–2032)
3.4.3 North America Infliximab Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infliximab Injection Market Facts & Figures by Country
3.5.1 Europe Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Infliximab Injection Sales by Country (2021–2032)
3.5.3 Europe Infliximab Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infliximab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Infliximab Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Infliximab Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Infliximab Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Infliximab Injection Market Facts & Figures by Country
3.7.1 Latin America Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Infliximab Injection Sales by Country (2021–2032)
3.7.3 Latin America Infliximab Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Infliximab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Infliximab Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Infliximab Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infliximab Injection Sales by Type (2021–2032)
4.1.1 Global Infliximab Injection Sales by Type (2021–2026)
4.1.2 Global Infliximab Injection Sales by Type (2027–2032)
4.1.3 Global Infliximab Injection Sales Market Share by Type (2021–2032)
4.2 Global Infliximab Injection Revenue by Type (2021–2032)
4.2.1 Global Infliximab Injection Revenue by Type (2021–2026)
4.2.2 Global Infliximab Injection Revenue by Type (2027–2032)
4.2.3 Global Infliximab Injection Revenue Market Share by Type (2021–2032)
4.3 Global Infliximab Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Infliximab Injection Sales by Application (2021–2032)
5.1.1 Global Infliximab Injection Sales by Application (2021–2026)
5.1.2 Global Infliximab Injection Sales by Application (2027–2032)
5.1.3 Global Infliximab Injection Sales Market Share by Application (2021–2032)
5.2 Global Infliximab Injection Revenue by Application (2021–2032)
5.2.1 Global Infliximab Injection Revenue by Application (2021–2026)
5.2.2 Global Infliximab Injection Revenue by Application (2027–2032)
5.2.3 Global Infliximab Injection Revenue Market Share by Application (2021–2032)
5.3 Global Infliximab Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Celltrion
6.1.1 Celltrion Company Information
6.1.2 Celltrion Description and Business Overview
6.1.3 Celltrion Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Celltrion Infliximab Injection Product Portfolio
6.1.5 Celltrion Recent Developments/Updates
6.2 Janssen Biologics
6.2.1 Janssen Biologics Company Information
6.2.2 Janssen Biologics Description and Business Overview
6.2.3 Janssen Biologics Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Janssen Biologics Infliximab Injection Product Portfolio
6.2.5 Janssen Biologics Recent Developments/Updates
6.3 Hangzhou Bozhirui Biopharmaceuticals
6.3.1 Hangzhou Bozhirui Biopharmaceuticals Company Information
6.3.2 Hangzhou Bozhirui Biopharmaceuticals Description and Business Overview
6.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolio
6.3.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
6.4 Taizhou Maiboteike Pharmaceuticals
6.4.1 Taizhou Maiboteike Pharmaceuticals Company Information
6.4.2 Taizhou Maiboteike Pharmaceuticals Description and Business Overview
6.4.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolio
6.4.5 Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
6.5 Yuxi Jiahe Biotechnology
6.5.1 Yuxi Jiahe Biotechnology Company Information
6.5.2 Yuxi Jiahe Biotechnology Description and Business Overview
6.5.3 Yuxi Jiahe Biotechnology Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolio
6.5.5 Yuxi Jiahe Biotechnology Recent Developments/Updates
6.6 Ayumi Pharmaceuticals
6.6.1 Ayumi Pharmaceuticals Company Information
6.6.2 Ayumi Pharmaceuticals Description and Business Overview
6.6.3 Ayumi Pharmaceuticals Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ayumi Pharmaceuticals Infliximab Injection Product Portfolio
6.6.5 Ayumi Pharmaceuticals Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Infliximab Injection Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Nichiiko
6.8.1 Nichiiko Company Information
6.8.2 Nichiiko Description and Business Overview
6.8.3 Nichiiko Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Nichiiko Infliximab Injection Product Portfolio
6.8.5 Nichiiko Recent Developments/Updates
6.9 Nippon Kayaku
6.9.1 Nippon Kayaku Company Information
6.9.2 Nippon Kayaku Description and Business Overview
6.9.3 Nippon Kayaku Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Nippon Kayaku Infliximab Injection Product Portfolio
6.9.5 Nippon Kayaku Recent Developments/Updates
6.10 AMGEN
6.10.1 AMGEN Company Information
6.10.2 AMGEN Description and Business Overview
6.10.3 AMGEN Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 AMGEN Infliximab Injection Product Portfolio
6.10.5 AMGEN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infliximab Injection Industry Chain Analysis
7.2 Infliximab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infliximab Injection Production Mode & Process Analysis
7.4 Infliximab Injection Sales and Marketing
7.4.1 Infliximab Injection Sales Channels
7.4.2 Infliximab Injection Distributors
7.5 Infliximab Injection Customer Analysis
8 Infliximab Injection Market Dynamics
8.1 Infliximab Injection Industry Trends
8.2 Infliximab Injection Market Drivers
8.3 Infliximab Injection Market Challenges
8.4 Infliximab Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Infliximab Injection by Type
1.2.1 Global Infliximab Injection Market Value by Type: 2025 vs 2032
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Infliximab Injection by Application
1.3.1 Global Infliximab Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Infliximab Injection Market Size Estimates and Forecasts
1.4.1 Global Infliximab Injection Revenue 2021–2032
1.4.2 Global Infliximab Injection Sales 2021–2032
1.4.3 Global Infliximab Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Infliximab Injection Market Competition by Manufacturers
2.1 Global Infliximab Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Infliximab Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Infliximab Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Infliximab Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Infliximab Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Infliximab Injection, Product Types and Applications
2.7 Global Key Manufacturers of Infliximab Injection, Date of Entry into the Industry
2.8 Global Infliximab Injection Market Competitive Situation and Trends
2.8.1 Global Infliximab Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Infliximab Injection Players Market Share by Revenue
2.8.3 Global Infliximab Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Infliximab Injection Market Scenario by Region
3.1 Global Infliximab Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Infliximab Injection Sales by Region: 2021–2032
3.2.1 Global Infliximab Injection Sales by Region: 2021–2026
3.2.2 Global Infliximab Injection Sales by Region: 2027–2032
3.3 Global Infliximab Injection Revenue by Region: 2021–2032
3.3.1 Global Infliximab Injection Revenue by Region: 2021–2026
3.3.2 Global Infliximab Injection Revenue by Region: 2027–2032
3.4 North America Infliximab Injection Market Facts & Figures by Country
3.4.1 North America Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Infliximab Injection Sales by Country (2021–2032)
3.4.3 North America Infliximab Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infliximab Injection Market Facts & Figures by Country
3.5.1 Europe Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Infliximab Injection Sales by Country (2021–2032)
3.5.3 Europe Infliximab Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infliximab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Infliximab Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Infliximab Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Infliximab Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Infliximab Injection Market Facts & Figures by Country
3.7.1 Latin America Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Infliximab Injection Sales by Country (2021–2032)
3.7.3 Latin America Infliximab Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Infliximab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Infliximab Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Infliximab Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Infliximab Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infliximab Injection Sales by Type (2021–2032)
4.1.1 Global Infliximab Injection Sales by Type (2021–2026)
4.1.2 Global Infliximab Injection Sales by Type (2027–2032)
4.1.3 Global Infliximab Injection Sales Market Share by Type (2021–2032)
4.2 Global Infliximab Injection Revenue by Type (2021–2032)
4.2.1 Global Infliximab Injection Revenue by Type (2021–2026)
4.2.2 Global Infliximab Injection Revenue by Type (2027–2032)
4.2.3 Global Infliximab Injection Revenue Market Share by Type (2021–2032)
4.3 Global Infliximab Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Infliximab Injection Sales by Application (2021–2032)
5.1.1 Global Infliximab Injection Sales by Application (2021–2026)
5.1.2 Global Infliximab Injection Sales by Application (2027–2032)
5.1.3 Global Infliximab Injection Sales Market Share by Application (2021–2032)
5.2 Global Infliximab Injection Revenue by Application (2021–2032)
5.2.1 Global Infliximab Injection Revenue by Application (2021–2026)
5.2.2 Global Infliximab Injection Revenue by Application (2027–2032)
5.2.3 Global Infliximab Injection Revenue Market Share by Application (2021–2032)
5.3 Global Infliximab Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Celltrion
6.1.1 Celltrion Company Information
6.1.2 Celltrion Description and Business Overview
6.1.3 Celltrion Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Celltrion Infliximab Injection Product Portfolio
6.1.5 Celltrion Recent Developments/Updates
6.2 Janssen Biologics
6.2.1 Janssen Biologics Company Information
6.2.2 Janssen Biologics Description and Business Overview
6.2.3 Janssen Biologics Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Janssen Biologics Infliximab Injection Product Portfolio
6.2.5 Janssen Biologics Recent Developments/Updates
6.3 Hangzhou Bozhirui Biopharmaceuticals
6.3.1 Hangzhou Bozhirui Biopharmaceuticals Company Information
6.3.2 Hangzhou Bozhirui Biopharmaceuticals Description and Business Overview
6.3.3 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product Portfolio
6.3.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
6.4 Taizhou Maiboteike Pharmaceuticals
6.4.1 Taizhou Maiboteike Pharmaceuticals Company Information
6.4.2 Taizhou Maiboteike Pharmaceuticals Description and Business Overview
6.4.3 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product Portfolio
6.4.5 Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
6.5 Yuxi Jiahe Biotechnology
6.5.1 Yuxi Jiahe Biotechnology Company Information
6.5.2 Yuxi Jiahe Biotechnology Description and Business Overview
6.5.3 Yuxi Jiahe Biotechnology Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Yuxi Jiahe Biotechnology Infliximab Injection Product Portfolio
6.5.5 Yuxi Jiahe Biotechnology Recent Developments/Updates
6.6 Ayumi Pharmaceuticals
6.6.1 Ayumi Pharmaceuticals Company Information
6.6.2 Ayumi Pharmaceuticals Description and Business Overview
6.6.3 Ayumi Pharmaceuticals Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ayumi Pharmaceuticals Infliximab Injection Product Portfolio
6.6.5 Ayumi Pharmaceuticals Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Infliximab Injection Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Nichiiko
6.8.1 Nichiiko Company Information
6.8.2 Nichiiko Description and Business Overview
6.8.3 Nichiiko Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Nichiiko Infliximab Injection Product Portfolio
6.8.5 Nichiiko Recent Developments/Updates
6.9 Nippon Kayaku
6.9.1 Nippon Kayaku Company Information
6.9.2 Nippon Kayaku Description and Business Overview
6.9.3 Nippon Kayaku Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Nippon Kayaku Infliximab Injection Product Portfolio
6.9.5 Nippon Kayaku Recent Developments/Updates
6.10 AMGEN
6.10.1 AMGEN Company Information
6.10.2 AMGEN Description and Business Overview
6.10.3 AMGEN Infliximab Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 AMGEN Infliximab Injection Product Portfolio
6.10.5 AMGEN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infliximab Injection Industry Chain Analysis
7.2 Infliximab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infliximab Injection Production Mode & Process Analysis
7.4 Infliximab Injection Sales and Marketing
7.4.1 Infliximab Injection Sales Channels
7.4.2 Infliximab Injection Distributors
7.5 Infliximab Injection Customer Analysis
8 Infliximab Injection Market Dynamics
8.1 Infliximab Injection Industry Trends
8.2 Infliximab Injection Market Drivers
8.3 Infliximab Injection Market Challenges
8.4 Infliximab Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Infliximab Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Infliximab Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Infliximab Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Infliximab Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Infliximab Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Infliximab Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Infliximab Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Infliximab Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Infliximab Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Infliximab Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Infliximab Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Infliximab Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infliximab Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Infliximab Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Infliximab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Infliximab Injection Sales by Region (K Units), 2021–2026
Table 18. Global Infliximab Injection Sales Market Share by Region (2021–2026)
Table 19. Global Infliximab Injection Sales by Region (K Units), 2027–2032
Table 20. Global Infliximab Injection Sales Market Share by Region (2027–2032)
Table 21. Global Infliximab Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Infliximab Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Infliximab Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Infliximab Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Infliximab Injection Sales by Country (K Units), 2021–2026
Table 27. North America Infliximab Injection Sales by Country (K Units), 2027–2032
Table 28. North America Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Infliximab Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Infliximab Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Infliximab Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Infliximab Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Infliximab Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Infliximab Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Infliximab Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Infliximab Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Infliximab Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Infliximab Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Infliximab Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Infliximab Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Infliximab Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Infliximab Injection Sales Market Share by Type (2021–2026)
Table 53. Global Infliximab Injection Sales Market Share by Type (2027–2032)
Table 54. Global Infliximab Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Infliximab Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Infliximab Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Infliximab Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Infliximab Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Infliximab Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Infliximab Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Infliximab Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Infliximab Injection Sales Market Share by Application (2021–2026)
Table 63. Global Infliximab Injection Sales Market Share by Application (2027–2032)
Table 64. Global Infliximab Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Infliximab Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Infliximab Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Infliximab Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Infliximab Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Infliximab Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Celltrion Company Information
Table 71. Celltrion Description and Business Overview
Table 72. Celltrion Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Celltrion Infliximab Injection Product
Table 74. Celltrion Recent Developments/Updates
Table 75. Janssen Biologics Company Information
Table 76. Janssen Biologics Description and Business Overview
Table 77. Janssen Biologics Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Biologics Infliximab Injection Product
Table 79. Janssen Biologics Recent Developments/Updates
Table 80. Hangzhou Bozhirui Biopharmaceuticals Company Information
Table 81. Hangzhou Bozhirui Biopharmaceuticals Description and Business Overview
Table 82. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product
Table 84. Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
Table 85. Taizhou Maiboteike Pharmaceuticals Company Information
Table 86. Taizhou Maiboteike Pharmaceuticals Description and Business Overview
Table 87. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product
Table 89. Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
Table 90. Yuxi Jiahe Biotechnology Company Information
Table 91. Yuxi Jiahe Biotechnology Description and Business Overview
Table 92. Yuxi Jiahe Biotechnology Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Yuxi Jiahe Biotechnology Infliximab Injection Product
Table 94. Yuxi Jiahe Biotechnology Recent Developments/Updates
Table 95. Ayumi Pharmaceuticals Company Information
Table 96. Ayumi Pharmaceuticals Description and Business Overview
Table 97. Ayumi Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Ayumi Pharmaceuticals Infliximab Injection Product
Table 99. Ayumi Pharmaceuticals Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Infliximab Injection Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Nichiiko Company Information
Table 106. Nichiiko Description and Business Overview
Table 107. Nichiiko Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Nichiiko Infliximab Injection Product
Table 109. Nichiiko Recent Developments/Updates
Table 110. Nippon Kayaku Company Information
Table 111. Nippon Kayaku Description and Business Overview
Table 112. Nippon Kayaku Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Nippon Kayaku Infliximab Injection Product
Table 114. Nippon Kayaku Recent Developments/Updates
Table 115. AMGEN Company Information
Table 116. AMGEN Description and Business Overview
Table 117. AMGEN Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. AMGEN Infliximab Injection Product
Table 119. AMGEN Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Infliximab Injection Distributors List
Table 123. Infliximab Injection Customers List
Table 124. Infliximab Injection Market Trends
Table 125. Infliximab Injection Market Drivers
Table 126. Infliximab Injection Market Challenges
Table 127. Infliximab Injection Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Infliximab Injection
Figure 2. Global Infliximab Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Infliximab Injection Market Share by Type: 2025 & 2032
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Infliximab Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Infliximab Injection Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Infliximab Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Infliximab Injection Market Size (US$ Million), 2021–2032
Figure 13. Global Infliximab Injection Sales (K Units), 2021–2032
Figure 14. Global Infliximab Injection Average Price (US$/Unit), 2021–2032
Figure 15. Infliximab Injection Report Years Considered
Figure 16. Infliximab Injection Sales Share by Manufacturers in 2025
Figure 17. Global Infliximab Injection Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Infliximab Injection Players: Market Share by Revenue in Infliximab Injection in 2025
Figure 19. Infliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Infliximab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 22. North America Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 23. United States Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 26. Europe Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 27. Germany Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Infliximab Injection Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Infliximab Injection Revenue Market Share by Region (2021–2032)
Figure 34. China Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 42. Latin America Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Infliximab Injection by Type (2021–2032)
Figure 53. Global Revenue Market Share of Infliximab Injection by Type (2021–2032)
Figure 54. Global Infliximab Injection Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Infliximab Injection by Application (2021–2032)
Figure 56. Global Revenue Market Share of Infliximab Injection by Application (2021–2032)
Figure 57. Global Infliximab Injection Price (US$/Unit) by Application (2021–2032)
Figure 58. Infliximab Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Infliximab Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Infliximab Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Infliximab Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Infliximab Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Infliximab Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Infliximab Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Infliximab Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Infliximab Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Infliximab Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Infliximab Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Infliximab Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Infliximab Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infliximab Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Infliximab Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Infliximab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Infliximab Injection Sales by Region (K Units), 2021–2026
Table 18. Global Infliximab Injection Sales Market Share by Region (2021–2026)
Table 19. Global Infliximab Injection Sales by Region (K Units), 2027–2032
Table 20. Global Infliximab Injection Sales Market Share by Region (2027–2032)
Table 21. Global Infliximab Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Infliximab Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Infliximab Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Infliximab Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Infliximab Injection Sales by Country (K Units), 2021–2026
Table 27. North America Infliximab Injection Sales by Country (K Units), 2027–2032
Table 28. North America Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Infliximab Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Infliximab Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Infliximab Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Infliximab Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Infliximab Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Infliximab Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Infliximab Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Infliximab Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Infliximab Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Infliximab Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Infliximab Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Infliximab Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Infliximab Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Infliximab Injection Sales Market Share by Type (2021–2026)
Table 53. Global Infliximab Injection Sales Market Share by Type (2027–2032)
Table 54. Global Infliximab Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Infliximab Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Infliximab Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Infliximab Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Infliximab Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Infliximab Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Infliximab Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Infliximab Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Infliximab Injection Sales Market Share by Application (2021–2026)
Table 63. Global Infliximab Injection Sales Market Share by Application (2027–2032)
Table 64. Global Infliximab Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Infliximab Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Infliximab Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Infliximab Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Infliximab Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Infliximab Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Celltrion Company Information
Table 71. Celltrion Description and Business Overview
Table 72. Celltrion Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Celltrion Infliximab Injection Product
Table 74. Celltrion Recent Developments/Updates
Table 75. Janssen Biologics Company Information
Table 76. Janssen Biologics Description and Business Overview
Table 77. Janssen Biologics Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Biologics Infliximab Injection Product
Table 79. Janssen Biologics Recent Developments/Updates
Table 80. Hangzhou Bozhirui Biopharmaceuticals Company Information
Table 81. Hangzhou Bozhirui Biopharmaceuticals Description and Business Overview
Table 82. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product
Table 84. Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
Table 85. Taizhou Maiboteike Pharmaceuticals Company Information
Table 86. Taizhou Maiboteike Pharmaceuticals Description and Business Overview
Table 87. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product
Table 89. Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
Table 90. Yuxi Jiahe Biotechnology Company Information
Table 91. Yuxi Jiahe Biotechnology Description and Business Overview
Table 92. Yuxi Jiahe Biotechnology Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Yuxi Jiahe Biotechnology Infliximab Injection Product
Table 94. Yuxi Jiahe Biotechnology Recent Developments/Updates
Table 95. Ayumi Pharmaceuticals Company Information
Table 96. Ayumi Pharmaceuticals Description and Business Overview
Table 97. Ayumi Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Ayumi Pharmaceuticals Infliximab Injection Product
Table 99. Ayumi Pharmaceuticals Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Infliximab Injection Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Nichiiko Company Information
Table 106. Nichiiko Description and Business Overview
Table 107. Nichiiko Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Nichiiko Infliximab Injection Product
Table 109. Nichiiko Recent Developments/Updates
Table 110. Nippon Kayaku Company Information
Table 111. Nippon Kayaku Description and Business Overview
Table 112. Nippon Kayaku Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Nippon Kayaku Infliximab Injection Product
Table 114. Nippon Kayaku Recent Developments/Updates
Table 115. AMGEN Company Information
Table 116. AMGEN Description and Business Overview
Table 117. AMGEN Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. AMGEN Infliximab Injection Product
Table 119. AMGEN Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Infliximab Injection Distributors List
Table 123. Infliximab Injection Customers List
Table 124. Infliximab Injection Market Trends
Table 125. Infliximab Injection Market Drivers
Table 126. Infliximab Injection Market Challenges
Table 127. Infliximab Injection Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Infliximab Injection
Figure 2. Global Infliximab Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Infliximab Injection Market Share by Type: 2025 & 2032
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Infliximab Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Infliximab Injection Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Infliximab Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Infliximab Injection Market Size (US$ Million), 2021–2032
Figure 13. Global Infliximab Injection Sales (K Units), 2021–2032
Figure 14. Global Infliximab Injection Average Price (US$/Unit), 2021–2032
Figure 15. Infliximab Injection Report Years Considered
Figure 16. Infliximab Injection Sales Share by Manufacturers in 2025
Figure 17. Global Infliximab Injection Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Infliximab Injection Players: Market Share by Revenue in Infliximab Injection in 2025
Figure 19. Infliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Infliximab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 22. North America Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 23. United States Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 26. Europe Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 27. Germany Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Infliximab Injection Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Infliximab Injection Revenue Market Share by Region (2021–2032)
Figure 34. China Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 42. Latin America Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Infliximab Injection by Type (2021–2032)
Figure 53. Global Revenue Market Share of Infliximab Injection by Type (2021–2032)
Figure 54. Global Infliximab Injection Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Infliximab Injection by Application (2021–2032)
Figure 56. Global Revenue Market Share of Infliximab Injection by Application (2021–2032)
Figure 57. Global Infliximab Injection Price (US$/Unit) by Application (2021–2032)
Figure 58. Infliximab Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232